mitoxantrone has been researched along with Anemia, Refractory, with Excess of Blasts in 9 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Anemia, Refractory, with Excess of Blasts: Chronic refractory anemia with granulocytopenia, and/or thrombocytopenia. Myeloblasts and progranulocytes constitute 5 to 40 percent of the nucleated marrow cells.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report the case of a 59-year-old woman treated for a refractory anemia with excess blasts (RAEB) who developed cytomegalovirus (CMV) colitis during induction therapy combining fludarabine, cytarabine and mitoxantrone." | 7.71 | Segmental coecal cytomegalovirus colitis during fludarabine, cytarabine and mitoxantrone induction chemotherapy for myelodysplastic syndrome. ( Antoun, S; Carpiuc, I; Delabarthe, A; Driss, B; Fenaux, R; Griscelli, F; Ribrag, V; Vantelon, JM, 2002) |
| "We report the case of a 59-year-old woman treated for a refractory anemia with excess blasts (RAEB) who developed cytomegalovirus (CMV) colitis during induction therapy combining fludarabine, cytarabine and mitoxantrone." | 3.71 | Segmental coecal cytomegalovirus colitis during fludarabine, cytarabine and mitoxantrone induction chemotherapy for myelodysplastic syndrome. ( Antoun, S; Carpiuc, I; Delabarthe, A; Driss, B; Fenaux, R; Griscelli, F; Ribrag, V; Vantelon, JM, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kikuchi, A | 1 |
| Hasegawa, D | 1 |
| Ohtsuka, Y | 1 |
| Hamamoto, K | 1 |
| Kojima, S | 1 |
| Okamura, J | 1 |
| Nakahata, T | 1 |
| Manabe, A | 1 |
| Carpiuc, I | 1 |
| Antoun, S | 1 |
| Delabarthe, A | 1 |
| Driss, B | 1 |
| Vantelon, JM | 1 |
| Griscelli, F | 1 |
| Fenaux, R | 1 |
| Ribrag, V | 1 |
| Delforge, M | 1 |
| Demuynck, H | 1 |
| Vandenberghe, P | 1 |
| Verhoef, G | 1 |
| Zachée, P | 1 |
| van Duppen, V | 1 |
| Marijnen, P | 1 |
| Van den Berghe, H | 1 |
| Boogaerts, MA | 1 |
| Roulston, D | 1 |
| Anastasi, J | 1 |
| Rudinsky, R | 1 |
| Nucifora, G | 1 |
| Zeleznik-Le, N | 1 |
| Rowley, JD | 1 |
| McGavran, L | 1 |
| Tsuchida, M | 1 |
| Hayashi, Y | 1 |
| Creutzig, U | 1 |
| Bender-Götze, C | 1 |
| Ritter, J | 1 |
| Zimmermann, M | 1 |
| Stollmann-Gibbels, B | 1 |
| Körholz, D | 1 |
| Niemeyer, C | 1 |
| Wattel, E | 1 |
| Solary, E | 1 |
| Hecquet, B | 1 |
| Caillot, D | 1 |
| Ifrah, N | 1 |
| Brion, A | 1 |
| Milpied, N | 1 |
| Janvier, M | 1 |
| Guerci, A | 1 |
| Rochant, H | 1 |
| Cordonnier, C | 1 |
| Dreyfus, F | 1 |
| Veil, A | 1 |
| Hoang-Ngoc, L | 1 |
| Stoppa, AM | 1 |
| Gratecos, N | 1 |
| Sadoun, A | 1 |
| Tilly, H | 1 |
| Brice, P | 1 |
| Lioure, B | 1 |
| Desablens, B | 1 |
| Pignon, B | 1 |
| Abgrall, JP | 1 |
| Leporrier, M | 1 |
| Fenaux, P | 1 |
| Bennett, JM | 1 |
| Young, MS | 1 |
| Liesveld, JL | 1 |
| Paietta, E | 1 |
| Miller, KB | 1 |
| Lazarus, HM | 1 |
| Marsh, RD | 1 |
| Friedenberg, WR | 1 |
| Saba, HT | 1 |
| Hayes, FA | 1 |
| Dewald, GW | 1 |
| Hiddemann, W | 1 |
| Rowe, JM | 1 |
| Linkesch, W | 1 |
| Thaler, J | 1 |
| Gattringer, C | 1 |
| Konwalinka, G | 1 |
| Brito-Babapulle, F | 1 |
| Lord, JA | 1 |
| Whitmore, DN | 1 |
1 review available for mitoxantrone and Anemia, Refractory, with Excess of Blasts
| Article | Year |
|---|---|
Therapy-related acute leukemia associated with t(11q23) after primary acute myeloid leukemia with t(8;21): a report of two cases.
Topics: Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents, Phytogenic; Antineoplastic Combine | 1995 |
2 trials available for mitoxantrone and Anemia, Refractory, with Excess of Blasts
| Article | Year |
|---|---|
Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS.
Topics: Adult; Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protoco | 1999 |
Phase II study of combination human recombinant GM-CSF with intermediate-dose cytarabine and mitoxantrone chemotherapy in patients with high-risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): an Eastern Cooperative Oncology Group Study.
Topics: Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Bon | 2001 |
6 other studies available for mitoxantrone and Anemia, Refractory, with Excess of Blasts
| Article | Year |
|---|---|
Outcome of children with refractory anaemia with excess of blast (RAEB) and RAEB in transformation (RAEB-T) in the Japanese MDS99 study.
Topics: Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Cell Tran | 2012 |
Segmental coecal cytomegalovirus colitis during fludarabine, cytarabine and mitoxantrone induction chemotherapy for myelodysplastic syndrome.
Topics: Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Cecal Dis | 2002 |
Polyclonal primitive hematopoietic progenitors can be detected in mobilized peripheral blood from patients with high-risk myelodysplastic syndromes.
Topics: Adult; Anemia, Refractory, with Excess of Blasts; Antigens, CD; Antigens, CD34; Antigens, Differenti | 1995 |
The role of intensive AML-specific therapy in treatment of children with RAEB and RAEB-t.
Topics: Adolescent; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocol | 1998 |
Continuous infusion of mitoxantrone combined with high-dose cytarabine in refractory/relapsed acute myeloblastic leukemia and blast crisis of chronic myelogenous leukemia.
Topics: Adolescent; Adult; Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemothe | 1990 |
Treatment of RAEB-t with intensive chemotherapy and GM-CSF.
Topics: Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Bone Marr | 1989 |